文献速递乳腺乳腺X线

新辅助化疗对乳腺组织构成的影响:采用自动体积测量的纵向乳腺X线研究

Effect of neoadjuvant chemotherapy on breast tissue composition: a longitudinal mammographic study with automated volumetric measurement.
PubMed 文献 · Eur Radiol · 2020-04-20

回顾性纳入168例接受新辅助化疗的乳腺癌患者,于治疗前、治疗中、治疗后行乳腺X线检查并以Volpara软件自动测量对侧乳腺体积、纤维腺体体积和乳腺密度。结果显示三者随时间显著下降,且下降模式不同;化疗方案、年龄和Volpara密度分级与部分参数变化独立相关,自动体积测量可捕捉这些定量变化。

要点

  • 新辅助化疗期间对侧乳腺体积、纤维腺体体积和乳腺密度均随时间显著下降。
  • 乳腺体积后半程降幅大于前半程,乳腺密度前半程降幅大于后半程。
  • 年龄、Volpara密度分级和化疗方案与乳腺密度变化独立相关。

关键影像表现/征象

  • 对侧乳腺体积、纤维腺体体积和乳腺密度随时间均显著下降(重复测量方差分析p<0.001、p<0.001、p=0.002)。
  • 乳腺体积后半程降幅大于前半程(-28.6 cm3 vs -15.2 cm3),乳腺密度前半程降幅大于后半程(-0.8% vs -0.1%)。
  • 纤维腺体体积持续下降,前半程和后半程分别减少4.6 cm3和3.9 cm3。

诊断标准与关键数值

  • 采用Volpara软件自动测量对侧乳腺体积、纤维腺体体积和乳腺密度,并按Volpara密度分级(VDG)将乳腺密度分为4组。
  • 多变量线性回归显示,化疗方案与治疗前至治疗后乳腺体积变化相关(p=0.002)。
  • 年龄(p=0.024)和VDG(p=0.027)与纤维腺体体积变化相关。
  • 年龄(p=0.037)、VDG(p=0.002)和化疗方案(p=0.003)与乳腺密度变化相关。

临床应用与阅片要点

  • 阅片时可关注新辅助化疗期间对侧乳腺体积、纤维腺体体积和乳腺密度的定量变化,自动体积测量可提供纵向定量信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the effect of neoadjuvant chemotherapy (NAC) on breast tissue composition with mammographic automated volumetric measurement.

METHODS: This retrospective study included 168 breast cancer patients who were treated with NAC and underwent serial mammography (pre-treatment, mid-treatment, and post-treatment) between January 2015 and October 2018. Automated volumetric measurements of the contralateral breast volume (BV), fibroglandular volume (FGV), and breast density (BD) were performed using Volpara software. BD grades were divided into 4 groups by Volpara density grade (VDG). The longitudinal changes in BV, FGV, BD, and their associated factors were evaluated.

RESULTS: Repeated-measures analysis of variance demonstrated a significant reduction in BV, FGV, and BD over time (p < 0.001, p < 0.001, and p = 0.002, respectively). BV showed a greater reduction in the second half than in the first half (- 28.6 cm3 vs. - 15.2 cm3), BD showed a greater reduction in the first half than in the second half (- 0.8% vs. - 0.1%), and FGV steadily decreased (- 4.6 cm3 and - 3.9 cm3 in the first and second halves). On multivariable linear regression analysis, chemotherapy regimen was associated with BV change between pre- and post-treatment (p = 0.002); age (p = 0.024) and VDG (p = 0.027) were associated with FGV change; age (p = 0.037), VDG (p = 0.002), and chemotherapy regimen (p = 0.003) were associated with BD change.

CONCLUSIONS: NAC affects breast tissue composition, reflected as reductions in BV, FGV, and BD. Mammography with automated volumetric measurement can capture quantitative changes in these breast tissue parameters during NAC.

KEY POINTS: • Neoadjuvant chemotherapy (NAC) affects breast tissue composition with different patterns of reduction in breast volume, fibroglandular volume, and breast density. • Age, Volpara density grades, and NAC regimen were independent factors associated with breast density change between pre-treatment and post-treatment. • Mammography with automated volumetric measurement enables identification of longitudinal changes in breast tissue composition.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Jang HJ, Kim HJ, Chae YS, et al. Effect of neoadjuvant chemotherapy on breast tissue composition: a longitudinal mammographic study with automated volumetric measurement. Eur Radiol. 2020. PMID: 32314056. doi:10.1007/s00330-020-06830-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。